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INTRODUCTION

Cytotoxic CD8
+ T cells (CD8 + CTLs) and CD4 + T helper (Th) cells are crucial for all adaptive immune responses during ongoing infections. CD8
+ CTLs kill target cells infected with intracellular pathogens, thereby removing sites of pathogen replication. Th cells are a subpopulation of CD4 + T cells which are specialized in providing supporting signals to other cells such as B cells and CD8 + T cells through either secretion of cytokines or direct cell-to-cell interactions. Th cells provide help to a number of key immune responses involved in controlling viruses, for example in lymphocytic choriomeningitis virus (LCMV) (Fayolle et al., 1991) , influenza virus (Graham et al., 1994) , vesicular stomatitis virus (Maloy et al., 1999) , polio virus (Mahon et al., 1995) and murine c herpes virus (Cardin et al., 1996) infections. The crucial importance of Th cells in viral immunity is vividly demonstrated in human immunodeficiency virus type 1 (HIV-1) infection, where Th cells are the main targets and are depleted by the virus. Absence of Th cells strongly affects the virus-specific cytotoxic T cell (CTL) (Altfeld & Rosenberg, 2000; Spiegel et al., 2000) and neutralizing antibody (Poignard et al., 1999) responses, resulting in AIDS. Furthermore, Th cells have been shown to induce direct antiviral effects via secretion of cytokines, such as gamma interferon (IFN-c) and tumour necrosis factors (TNF) (Gagnon et al., 1999) , in murine infections of LCMV (Varga & Welsh, 1998) , herpes simplex virus (HSV) (Manickan et al., 1995) , vaccinia virus (VV) (Maloy et al., 2000) and measles virus (Reich et al., 1992) . IFN-c-producing Th cells are also present in HIV-1 infection (Littaua et al., 1992; Norris et al., 2001; Sethi et al., 1988) . Moreover, C-C chemokines secreted by Th cells suppress infection by chemokine receptor-5-dependent HIV-1 viruses (Furci et al., 1997) . However, most of the findings on mechanisms of Th-cellmediated protection in HIV-1 have been obtained during the chronic stages of infection. This is because primary HIV-1 infection is asymptomatic, so very few patients are available for immunological studies. HIV vaccine research would highly benefit from additional knowledge about the initial interaction of retroviruses with CD4 + Th cells during acute infection.
Mouse models of HIV infection are not available and, as a result, the Friend retrovirus (FV) model has been used extensively to study the mechanisms of immunity against retroviruses (Hasenkrug & Chesebro, 1997; Hasenkrug & Dittmer, 2000) . FV is a retroviral complex that induces lethal erythroleukaemia in susceptible strains of mice (Dittmer & Hasenkrug, 2001; Hasenkrug & Dittmer, 2000) . However, mice that mount efficient immune responses against the virus due to their major histocompatibility complex (MHC) background are resistant to leukaemia (Chesebro et al., 1990) . Recovery from acute infection is dependent upon cytotoxic killing of FVinfected cells by CD8 + CTLs (Zelinskyy et al., 2004) . On the other hand, Th cells are known to be critical in controlling FV replication and spread in persistently infected mice (Hasenkrug et al., 1998a) . Moreover, vaccination studies suggested the crucial importance of Th cells, CTLs and B cells for the induction of complete protection against FV infection (Dittmer et al., 1999) . Also, CD4
+ T cells were required for recovery in at least 50 % of the resistant mice infected with FV (Robertson et al., 1992) . However, in that study, effector functions of Th cells were not investigated and, moreover, there were no tools available for quantification of Th-cell responses. Furthermore, experiments were performed with a contaminated FV stock containing lactate dehydrogenase virus (LDV), which can delay immune responses against FV (Robertson et al., 2007) . Therefore, we investigated the role of Th cells during acute FV infection using an LDV-free FV stock and also characterized the effector functions of Th cells. Here, we show that Th cells played a cardinal role in limiting the pathological consequences during acute FV infection by mediating help to CD8 + T cells and B cells. Furthermore, the magnitude of FV-specific effector Th-cell responses was found to be dependent on the MHC background of infected mice.
In spite of an effective CD8 + T-cell immune response during an acute FV infection, high recovery mice are never able to clear the virus completely, and remain persistently infected for life (Dittmer & Hasenkrug, 2001; Hasenkrug & Dittmer, 2000) . During bacterial, parasitic and viral infections, immunosuppressive regulatory T cells (Tregs) expand, which dampens T-cell responses (Robertson & Hasenkrug, 2006) . In some viral infections, the immune response is more detrimental than the virus itself, but immunosuppression by Tregs can prevent pathology in the host. However, immunosuppressive effects on T cells can also be beneficial to the virus, by prolonging recovery of the infected host, leading to persistent infections. Functional impairment of FV-specific CD8 + T cells in persistent FV infections is mediated by Tregs Zelinskyy et al., 2006) . Importantly, these Tregs expand 2-3 weeks after acute FV infection and consequently suppress the functions of effector CD8 + T cells. In addition, Antunes et al. (2008) 
RESULTS
Th cells are important in controlling viral replication and preventing erythroleukaemia during acute FV infection
Th cells are important in vaccine-induced protection against FV infections (Dittmer & Hasenkrug, 2000) and in restricting FV replication and spread in persistently infected mice (Hasenkrug et al., 1998a) . Additionally, deficiency of CD4 + T cells resulted in leukaemia in almost 50 % of FV-resistant animals during acute FV infection (Robertson et al., 1992) . However, the mechanisms underlying the influence of CD4 + T cells on recovery from FV-induced disease remain elusive. To better understand the importance of CD4 + T cells in recovery from FV infection, mice were injected with anti-CD4 monoclonal antibodies to deplete CD4 + T cells, while control animals received PBS. The effectiveness of CD4 depletion was greater than 98 %. After 1 week, CD4-depleted mice and non-depleted controls were infected with FV. Spleens from these mice were palpated at weekly intervals to monitor splenomegaly (Hasenkrug et al., 1998a) . CD4-depleted mice had much enlarged spleens compared with non-depleted mice at 4 weeks p.i. This time point was chosen to determine how CD4 T-cell depletions affected FV-induced erythroleukaemia and spleen viral loads. CD4
+ T-cell numbers were still reduced in depleted mice, indicating that the effect of depletion lasts for at least 4 weeks. The mean spleen weight of CD4-depleted mice was 2.6 g at this time point (Fig. 1a) . This was in sharp contrast with the spleen weights of non-depleted mice, which had a mean spleen weight of 0.21 g, indicating that FV-induced disease had resolved by that time. These results suggest that the absence of CD4 + T cells affects the normal recovery from FV-induced disease and results in gross splenomegaly. Infectious centres (IC) assays were performed to determine whether the depletion of CD4 + T cells affected levels of viral replication in the spleen. The assay revealed that there were significantly more ICs in CD4-depleted mice (mean51.375610 8 ) than in nondepleted mice (mean52.376610 3 ) (Fig. 1b) . Thus, the depletion of the CD4 + T-cell population resulted in increased FV replication during the recovery phase of FV infection (4 weeks p.i.) and progression to FV-induced erythroleukaemia in the resistant mouse strain (C57BL/ 106A.BY) F 1 .
CD4
+ T-cell help is essential for the maintenance of FV-specific effector and memory CD8 + T-cell responses and for efficient antibody responses during acute FV infection
We have established that CD4 depletions resulted in the loss of immunity to FV infection in resistant mice. The mechanisms by which CD4 + T cells mediated protection against FV were of relevance to our study. + T cells in spleens of CD4-depleted mice compared with nondepleted mice (Fig. 2a) . Th cells are also known to be important for the maintenance of the long-lived memory CD8 + T-cell pool (Buller et al., 1987; Janssen et al., 2003; Shedlock & Shen, 2003; Sun & Bevan, 2003 (Fig. 2b ). It has been described previously that, at 7 and 14 days p.i., FV-specific effector CD8
+ T-cell responses in spleens were not affected by CD4 + T-cell depletions (Robertson et al., 2007) . Thus, it is apparent that early recovery from FV infections mediated by CD8
+ T-cell responses is CD4 + T-cell-independent, but long-term maintenance of memory CD8 + T-cell responses requires help from CD4 + T cells.
+ T-cell help is indispensable for the production of neutralizing antibodies in various infections. Furthermore, virus-neutralizing antibodies are essential for recovery from FV infection, as concluded from vaccine studies. Hence, to determine whether B cells require help from Th cells for secretion of antibodies, plasma samples from CD4-depleted and non-depleted mice were tested for FV-specific antibody levels. At 4 weeks p.i., the mean Friend murine helper virus (F-MuLV)-specific binding antibody titre and the neutralizing titre for FV-infected non-depleted mice were significantly higher compared with the mean titres of CD4-depleted FV-infected mice (Fig. 2c) . Thus, Th cells were critical for aiding B cells to induce virus-specific antibodies. In vivo depletion of Th cells in acute FV infection demonstrated that Th cells were critical for the maintenance of CD8 and neutralizing antibody responses.
Resistance to FV-induced disease correlates with the magnitude of H-2A-restricted CD4 + T-cell responses
It is known that recovery from FV-induced disease depends upon an array of genes mapped to the MHC H-2 region of mice, of which H-2A can influence the effectiveness of Thcell responses (Chesebro et al., 1990) . Additionally, immunization with a single Th-cell epitope in the gp70 envelope (Env) glycoprotein of F-MuLV induced potent A b -restricted Th-cell responses that conferred partial This kinetic study showed that the peak of the FV-specific effector Th-cell response was at 10 days p.i. (Fig. 3a) . Interestingly, there was a significant difference in peak CD4
+
Tet
+ T-cell responses, with high recovery mice having 58 % more virus-specific CD4 + T cells than intermediate recovery mice. In addition, the percentage of total CD4 + T cells expressing the effector cell markers CD43 and CD69 was also higher in high recovery mice than intermediate recovery mice at 10 days p.i. (Fig. 3b) . Therefore, we observed a significant difference in overall activation of effector Th cells and FV-specific T-cell responses between high and intermediate recovery mice. Thus, the resistance of mice to FV-induced disease correlated with the magnitude of the H-2A-restricted CD4 + T-cell response. These data support findings from the FV vaccination experiment which demonstrated that the H-2A b/b genotype influenced CD4 + T-cell-mediated immune responses (Chesebro et al., 1990; Miyazawa et al., 1988) . From these studies, we knew that resistance to FV infection was dependent on the MHC background. However, for the first time, the population of H-2A brestricted FV-specific CD4 + T cells in mice with a different recovery status could be accurately quantified using class-II tetramers. Thus, our study suggests that the differential resistance to FV infection in mice expressing different levels of H-2A b was at least in part due to the difference in the magnitude of CD4 + T-cell responses.
FV-specific CD4 + TCRb-tg T cells produce IFN-c and reduce viral loads in FV-infected mice
Using adoptively transferred FV-specific CD8 + T cells from CD8 + T-cell receptor transgenic mice, it was shown that such cells dramatically reduce viral loads during acute FV infection, but fail to reduce viral loads in persistently infected mice ). In the current study, we address the antiviral activity of CD4 + T cells during different phases of FV infection. We made use of CD4 + TCRb-tg mice transgenically expressing the TCRb chain (Antunes et al., 2008) that recognizes the FV-specific CD4 + T-cell epitope H19-Env. In principle, these FVspecific T cells have been shown to reduce FV loads in vivo (Antunes et al., 2008) .
Donor CD4
+ T cells from transgenic mice were differentiated from the endogenous host T cells of recipient mice on the basis of congenic markers. T cells from donor mice express CD45.1, while T cells from the recipients express CD45.2. For the present study, only antigen-inexperienced 
Role of CD4 + T cells in acute FV infection
(CD43 low and CD62L high ) cells were utilized for the adoptive transfer experiment. One week after adoptive transfer of CD4 + TCRb-tg T cells into FV-infected recipient mice, CD4
+ T cells were reisolated and analysed by flow cytometry. Adoptive transfer of FV-specific TCRbtg CD4 + T cells into naïve control mice indicated that only poor expansion of the donor cells occurs when no specific antigen is present. However, a strong expansion of FVspecific TCRb-tg CD4 + T cells was observed after transfer into mice infected with FV for 1, 2 or 3 weeks; representative data are shown in Fig. 4(a) . Furthermore, expansion of the donor cells was paralleled by an activation of the cells after recognizing their cognate antigen. Whereas very few cells that were recovered from naïve mice displayed an effector phenotype (CD43 high and CD62L low ), the numbers of effector CD4 + T cells was strongly increased after transfer into infected mice. The highest percentages of CD4 + TCRb-tg T cells with effector phenotype were reisolated from animals infected with FV for 1 week (Fig. 4b) . Nevertheless, it was also observed that CD4 + TCRb-tg T cells transferred into mice infected with FV for 3 weeks were significantly activated.
To examine the functional role of the adoptively transferred CD4
+ TCRb-tg T cells during acute FV infection, intracellular cytokine staining for IFN-c was performed at 1 week post-transfer. The percentage of IFN-c-producing donor CD4
+ T cells in mice infected with FV for 1 or 2 weeks was significantly elevated compared with donor CD4 + T cells transferred into naïve control mice (Fig. 4c) . In contrast, the transfer of FV-specific CD4
+ TCRb-tg T cells into mice infected with FV for 3 weeks did not result in significant induction of IFN-c-producing cells, despite the fact that expansion and activation of these cells was detected at this time point.
Our previous work demonstrated a similar dysfunction of FV-specific CD8 + T cells, which were unable to produce IFN-c and cytolytic molecules following adoptive transfer into persistently infected mice even though they had an effector phenotype Zelinskyy et al., 2005) . To probe further whether transferred FV-specific CD4 + TCRb-tg T cells with effector phenotype were producing IFN-c, we performed a co-staining experiment for intracellular IFN-c production and CD43 expression. A significant number of donor CD4 + T cells reisolated from recipient mice infected for 1 or 2 weeks had an effector phenotype and produced IFN-c. However, in spite of sufficient activation, donor CD4 + T cells reisolated from mice infected with FV for 3 weeks did not significantly produce IFN-c (Fig. 4d) .
Given the rapid expansion and activation of the FV-specific CD4 + T cells in response to their cognate viral antigen, it was of interest to determine whether the transferred cells had any effect on viral loads during acute FV infection. At 1 week post-transfer, the mean IC levels in mice infected for 1 week were reduced from 3610 7 cells to 4610 5 cells per spleen, a reduction of almost 100-fold (Fig. 4e) . Similarly, an approximately 75-fold reduction in viral loads was observed in mice infected with FV for 2 weeks that received CD4 + TCRb-tg T cells (Fig. 4e) . In contrast, CD4 + TCRbtg T cells transferred into mice infected with FV for 3 weeks did not have the capacity to reduce viral loads in vivo (Fig. 4e) .
These results indicated that the CD4 + TCRb-tg T cells were effective at reducing viral loads in mice infected with FV for 1 or 2 weeks but were ineffective at reducing viral loads in mice infected with FV for 3 weeks. Thus, although the FV-specific CD4 + T cells expanded and upregulated the activation marker CD43 following adoptive transfer into infected mice, the cells were functionally impaired in mice infected with FV for 3 weeks (Fig. 4d) , resulting in loss of their antiviral activity.
Suppression of FV-specific CD4
+ T-cell responses by regulatory T cells
We previously reported that the functional impairment of FV-specific CD8 + T cells during chronic infection is mediated by CD4 + Foxp3 + Tregs, which expand during the late phase of acute FV infection (2-3 weeks p.i.) Zelinskyy et al., 2006 ). In the current study, we speculated that the low frequency of IFN-cproducing FV-specific CD4
+ T cells at 3 weeks p.i. could also be a result of Treg-mediated CD4 + T-cell dysfunction. To determine whether Tregs were inhibiting the antiviral functions of virus-specific CD4 + Th cells, we used a mouse model in which Foxp3-expressing Tregs can be experimentally depleted with diphtheria toxin (DT) treatment.
As recipient mice for CD4
+ TCRb-tg T-cell transfers, we used high-recovery DEREG.Y10 mice expressing the congenic marker CD45.2.
Downregulation of IFN-c responses in donor CD4
+ T cells was observed in mice infected with FV for 3 weeks. Therefore, for the current study, naïve FV-specific CD4 + TCRb-tg T cells were transferred into DEREG.Y10 mice infected with FV for 3 weeks. At the same time, FV-infected recipient mice received DT to deplete Tregs. On day 7, 97 % ablation of CD4 + Foxp3 + GFP + Tregs in DT-treated DEREG.Y10 mice was observed. CD4
+ TCRb-tg T cells transferred into DEREG.Y10 mice infected with FV for 3 weeks and depleted for Tregs was associated with a significant rise in the percentage of IFN-c-producing CD4 + T cells of both host and donor origin compared with non-Treg-depleted mice (Fig. 5a, b) . Thus, the removal of Tregs restored the loss in IFN-c production by CD4 + T cells. Consequently, it was of interest to determine the outcome of Treg depletion on viral loads after transfer of FV-specific CD4 + TCRb-tg T cells. Unexpectedly, the transfer of CD4 + TCRb-tg T cells at 3 weeks p.i. even increased viral loads in DEREG.Y10 mice (Fig. 5c) , which was not the case in wild-type mice (Fig.  4e) . However, we found an apparent reduction in viral loads in FV-infected DEREG.Y10s that received FV-specific CD4 + TCRb-tg T cells and were depleted of Tregs (Fig. 5c ) that correlated with elevated IFN-c responses by the transferred CD4 + TCRb-tg T cells (Fig. 5a ). Hence, it is clearly evident that Tregs play a crucial antiviral role in suppressing immune functions of Th cells in the late phase of acute FV infection.
DISCUSSION
Th cells represent a critical and integral part of a functional immune system and are well characterized in many viral infections, but their antiviral role in retroviral immunity is poorly understood. The focus of this study was to elucidate the role of Th cells during acute FV infection. In vivo depletion of CD4 + T cells underscored the vital role of Th cells in controlling viral spread and the onset of FV-induced erythroleukaemia. It has been shown previously that recovery from acute FV infection requires strong effector responses elicited by CD8 + CTLs that control viral replication (Zelinskyy et al., 2004) . On the other hand, restriction of persistent FV infection is CD8
+ T-cell-independent and solely dependent upon CD4
+ T-cell effector responses (Hasenkrug et al., 1998a) . Our results reveal that, in spite of effective CD8 + T-cell responses during acute FV infections, the absence of CD4 + T cells in high recovery mice rendered them susceptible to FV-induced disease. In this respect, CD4
+ T cells are substantially crucial for controlling FV replication during acute infection.
In the current study, we explored the mechanisms of Thcell-mediated immunity during acute FV infections. Numerous studies have defined the role of CD4 + T cells in providing 'help' to key immune functions of CD8 + T cells and B cells involved in antiviral immunity. Our results clearly support this concept for retroviral infections. However, the requirement of CD4 + T cells in helping CD8
+ T-cell responses against pathogens remains a controversial field. It has been well documented for several murine infections that CD4 + T-cell help is not needed during the priming phase of CD8 + T-cell responses (Buller et al., 1987; Janssen et al., 2003; Novy et al., 2007; Shedlock & Shen, 2003; Sun & Bevan, 2003) . This lack of requirement for CD4 + T cells during the programming phase of infection is probably because most pathogens elicit strong inflammatory stimuli that directly activate antigen-presenting cells (Buller et al., 1987; Wu & Liu, 1994) . This is in agreement with our previous work which showed that the absence of CD4 + T cells during the early phase (up to 2 weeks) of FV infection did not influence FVspecific CD8
+ T-cell responses in FV-infected mice (Robertson et al., 2007) . In contrast, primary CD8 + Tcell responses to other pathogens are dependent on help from CD4 + T cells (Marzo et al., 2004; Riberdy et al., 2000; Smith et al., 2004; Yang et al., 1995) . Interestingly, we demonstrate here that, during the late phase of acute infection (4 weeks p.i.), deficiency of CD4 + T cells in FVinfected mice affected the maintenance of FV-specific effector CD8
+ T-cell responses. In HIV-1 infection, the ability of virus-specific CD8 + T cells to secrete IFN-c is compromised due to lack of help from CD4 + T cells (Spiegel et al., 2000) . In other infection models, Th cells were also required during the maintenance phase of the long-lived memory CD8 + T-cell pool (Buller et al., 1987; Janssen et al., 2003; Shedlock & Shen, 2003; Sun & Bevan, 2003) . CD4 + T-cell help provided during the primary response against infections such as those caused by LCMV, VV and Listeria monocytogenes delivers the necessary instructive signals for the generation of fully functional memory CD8 + T cells (Janssen et al., 2003; Shedlock & Shen, 2003) . In line with this theory, we provide evidence that, during the late acute phase of FV infection, mice lacking CD4 + T cells had poor expansion of FV-specific CD8 + T cells expressing the memory cell marker CD127. Thus, Th cells seem to be critical for the induction of retrovirus-specific CD8
+ memory T-cell responses. This finding might be of interest for the development of retroviral vaccines.
Induction of antiviral neutralizing antibodies in conjunction with cellular immune responses is an important mode of defence against most viruses. Lack of HIV-1-specific Th cells in established HIV-1 infection hampers the host's ability to generate effective antibody responses (Pantaleo & Walker, 2001) . In FV infection too, spontaneous recovery from FV requires the induction of virus-neutralizing antibodies (Chesebro & Wehrly, 1979) . In the present study, the lack of help from CD4 + T cells resulted in significant loss of FV-specific neutralizing antibodies during acute FV infection. However, we cannot rule out that low antibody titres in CD4-depleted mice may have been partially influenced by high viral loads, as antibodies may have been bound to viral particles. Therefore, our results suggest that CD4 + T cells are important for the production of FV-specific antibodies in acute retroviral infection. Besides, vaccine studies emphasize the importance of virus-neutralizing antibodies along with the priming of T cells for sterilizing immunity against FV (Dittmer et al., 1999) . Thus, it is apparent that Th cells contribute towards B-cell and CD8 + T-cell responses, thereby influencing recovery from FV-induced disease during acute infection.
The recovery of mice from FV-induced disease depends upon their H-2A genotype, which influences the FVspecific CD4
+ T-cell response against FV (Chesebro et al., 1990 ). However, how the H-2A genotype influences the quantity of the CD4 + T-cell responses against FV had not been investigated. Here, we used MHC class-II tetramers for the first time to compare the kinetics of CD4 + T-cell responses against FV in high and intermediate recovery mice. Our study extends earlier results to show that resistance to FV-induced disease correlated with the magnitude of H-2A b -restricted CD4 + T-cell responses (Chesebro et al., 1990; Miyazawa et al., 1995) . This might be because high recovery mice may be able to present more CD4 epitopes due to the 100 % H-2A (Martin & Carrington, 2005) . Thus, strategies for vaccine development need to consider the genetic diversity of immune response genes that can influence resistance or susceptibility to several different diseases.
Apart from being the 'helper' arm of the immune system, CD4 + T cells can have direct antiviral activities. CD4 + T cells have been described to induce direct anti-leukaemic effects in FV-infected mice progressing to erythroleukaemia (Pourbohloul et al., 1992) . One mechanism of antiviral activity of CD4 + T cells is the production of cytokines such as IFN-c and TNF-a (Gagnon et al., 1999) . IFN-c production by CD4 + T cells is a key component in the control of persistent FV infection in mice (Stromnes et al., 2002) . In the current study, we investigated the direct antiviral effect of FV-specific Th cells using CD4
+ TCRb-tg cells specific for the F-MuLV Env epitope. Transfer of such cells into acutely infected mice did not affect secondary immune responses like CD8 + T-cell and B-cell responses (data not shown). This suggests that the antiviral immunity detected after transfer of CD4 + TCRb-tg T cells was due to the direct effect of these cells. Adoptively transferred FVspecific CD4
+ TCRb-tg T cells rapidly expanded and became activated in acutely infected mice. Donor CD4 + T cells displayed IFN-c responses until 2 weeks p.i. This correlated with a significant reduction in viral loads in recipient mice. IFN-c-producing CD4 + T cells were also observed in the HBV transgenic mouse model (Franco et al., 1997) . Additionally, IFN-c production by HIV-1-specific CD4 + T cells is associated with control of viraemia in HIV-infected individuals (Rosenberg et al., 1997) .
However, the effector functions of FV-specific CD4 + T cells were lost 3 weeks after FV infection, with a dramatic drop in the frequency of IFN-c-producing cells. Consequently, the donor cells were unable to reduce viral loads. Thus, although FV-specific CD4 + T cells expanded and upregulated the activation markers following adoptive transfer, the cells were functionally impaired at 3 weeks p.i. A similar downregulation in effector functions has already been shown for FV-specific CD8 + T cells with the effector phenotype during chronic FV infection . These cells fail to produce IFN-c and the cytolytic molecules and hence are unable to degranulate and kill FV-labelled target cells in vivo (Zelinskyy et al., 2005) . Contemporaneous with the development of CD8 + T-cell dysfunction, which already begins at 2-3 weeks p.i., is the peak expansion of Tregs (Zelinskyy et al., 2006) . Several studies have also reasoned that the expansion of Tregs is a strategy to suppress antiretroviral CTL responses (Iwashiro et al., 2001a; Dittmer et al., 2004 , Estes et al., 2006 .
In our study, the downregulation in IFN-c production by FV-specific CD4 + T cells during acute FV infection was observed around the same time of peak Treg expansion. In order to elucidate the role of Tregs in inhibiting CD4 + Tcell responses, we used the DEREG mouse model. DEREG.Y10 mice infected with FV for 3 weeks had a sharp augmentation in IFN-c production by adoptively transferred FV-specific CD4 + T cells after the depletion of Foxp3 + Tregs. Therefore, our results clearly provide substantial evidence for the immunosuppressive role of Tregs leading to CD4 + T-cell dysfunction. This is in contrast with a recent finding, which emphasized that Tregs facilitate protective immunity to HSV infection (Lund et al., 2008) . Lund et al. (2008) showed that ablation of Tregs in HSV-2-infected DEREG mice interfered with the trafficking of T cells to the vaginal mucosa, the site of viral replication. In contrast with HSV infection, the site of pathogen replication during FV infection is the lymphoid tissues. This might explain the differences in the outcome of the two studies. Nevertheless, our study clearly indicated that Tregs were involved in suppression of antiviral CD4 + T-cell responses during an acute retroviral infection. Additionally, we have recently shown that short-term depletion of Tregs did not result in severe immunopathology during acute FV infection (Zelinskyy et al., 2009 ).
From the current findings, it is conceivable that Th cells are indispensable for resistance to acute FV infection. Th cells mediate help to B cells and CD8
+ T-cell responses during acute FV infection and therefore it becomes imperative to include Th cells in the development of retroviral vaccines. Moreover, our results also establish that Th cells have direct anti-retroviral effects on replicating virus and this anti-retroviral immunity can be suppressed by Tregs. Therefore, these aspects of CD4
+ T-cell immune responses also need to be taken into account when designing antiretroviral vaccines.
METHODS
Mice. Experiments were done using (H-2 b/b ) (C57BL/106A.BY) F 1 mice (Jackson Labs) that are resistant to FV-induced leukaemia. FVsusceptible (H-2 b/k ) (C57BL/10.A6A.BY) F 1 mice (Jackson Labs) were utilized for class-II tetramer studies. FV-specific CD4 + TCRb-tg mice, which carry a TCR transgene that is specific for the Env protein of F-MuLV (Antunes et al., 2008) , were back-crossed with CD45.1-congenic C57BL/6 mice. DEREG mice (Lahl et al., 2007) (Tim Sparwasser, Rocky Mountain Labs, Montana, USA) were crossed once with (C57BL/106A.BY) F 1 mice and were referred to as DEREG.Y10. The mice used were sex-and age-matched, and maintained under pathogen-free conditions.
Virus and viral infection. The FV stock was an FV complex containing B-tropic F-MuLV and polycythemia-inducing spleen focus-forming virus (Chesebro et al., 1990 ) (Bruce Cheesebro, Rocky Mountain Labs, Montana, USA). The stock was prepared as a 15 % spleen homogenate as described by Hasenkrug et al. (1998b) . The stock was free of contamination from LDV. Mice were infected intravenously with 0.5 ml PBS containing 6000-20 000 spleen focusforming units of FV.
In vivo T-cell depletion. (C57BL/106A.BY) F 1 mice were depleted of CD4
+ T cells by injecting them intraperitoneally with 0.5 ml supernatant fluid obtained from hybridoma cell cultures for CD4-specific monoclonal antibody YTS 191.1. CD4 depletion was carried out at days 26, 24, 22 and at 0, 2 and 4 days p.i. with FV. Depletion of Tregs was carried out in DEREG.Y10 mice by injecting each mouse intraperitoneally on alternate days for 1 week with 1 mg DT (Merck) diluted in endotoxin-free PBS.
IC assay. The IC assay described by Robertson et al. (1991) was used to determine the number of IC in the spleen.
Virus-neutralizing antibody assay. The assay was performed as described by Morrison et al. (1987) . The titre was defined as the plasma dilution at which .75 % of F-MuLV was neutralized.
F-MuLV-binding antibody ELISA. ELISA plates (Nunc) were coated with whole F-MuLV antigen, blocked with fetal calf serum (Biochrom), and incubated with serum dilutions. Binding antibodies were detected using a polyclonal anti-mouse horseradish peroxidase-coupled anti-IgG antibody (Dianova) and the substrate O-phenylenediamine (SigmaAldrich). Sera were considered positive if the optical density at 492 nm was threefold higher than that obtained with sera from naïve mice.
Surface and intracellular staining, and flow cytometry.
Antibodies used for cell-surface staining were anti-CD4 (GK 1.5), anti-CD8 (53-6.7), anti-CD43 (1B11), anti-CD45.1 (A20), anti-CD69 (H1.2F3), anti-CD127 (SB/199), anti-CD62L (MEL-14), anti-Mac-1 (WT.5), anti-Va2 TCR (B20.1) and Fc block anti-mouse CD16/CD32 (all from BD Biosciences). Dead cells were excluded by using 7-aminoactinomycin D (Molecular Probes). IFN-c production (He et al., 2004; Peterson et al., 2000) and Foxp3 expression were detected by intracellular staining using the Foxp3 staining kit (eBioscience) as described by Zelinskyy et al. (2006) . Data were acquired on a FACSCalibur and a LSR II flow cytometer (Becton Dickinson). Analyses were done using Becton Dickinson Cellquest Pro and FlowJo software version 7.2.5 (Tree Star).
Adoptive cell transfers. The midi MACS Separation system (Miltenyi Biotec) was used for the isolation of CD4 + T cells. The purity of the cell fractions was .90 % in all cases. The enriched fraction of CD4 + T cells was stained for CD43 and CD62L to verify their naïve phenotype. Adoptive transfers were done by intravenous injection of 7.5610 6 cells in PBS. Recipient mice were infected with FV and received CD4 + T cells at 3, 14 or 21 days p.i. Seven days posttransfer, spleen samples were assayed for viral load and expression of IFN-c, Foxp3 and surface markers. + T cells. Nucleated spleen cells were incubated with PElabelled I-A b tetramers for 2-3 h at 37 uC and later stained with anti-CD4 and anti-Mac-1 for 15 min at room temperature. For the detection of activated virus-specific CD8 + T cells, spleen cells were stained with anti-CD8, anti-CD43 and PE-labelled MHC class I H-2D b tetramers specific for the immunodominant GagL CTL epitope gPr80 gag 85-93 (Zelinskyy et al., 2006) .
Statistical analyses. Statistical analyses and graphical presentations were computed with GRAPH PAD PRISM version 5. Statistical differences (P values) were analysed by using the Mann-Whitney U test.
